Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2026-06-26 @ 4:32 AM
Study NCT ID:
NCT03850366
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Sponsor:
Henry Ford Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
10313
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None